Morgan Stanley Maintains Underweight on Walgreens Boots Alliance, Lowers Price Target to $20
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Erin Wright maintains an Underweight rating on Walgreens Boots Alliance (WBA) and lowers the price target from $21 to $20.

April 01, 2024 | 6:19 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley maintains an Underweight rating on Walgreens Boots Alliance, with a reduced price target from $21 to $20.
The reduction in price target by a major analyst like Morgan Stanley suggests a bearish outlook on WBA's stock, likely due to perceived challenges or underperformance. This could lead to a negative short-term impact on the stock's price as market participants adjust their expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100